Photo taken from Steven O'Day/LinkedIn
Oct 15, 2023, 19:05
Steven O’Day: I am thrilled to be joining Dr. Benjamin Schlechter, Dr. Pashtoon Kasi, and Phuong Ly-Gallagher for an engaging discussion on “The Next I-O Revolution”.
Steven O’Day, Chief Medical Officer at Agenus, recently shared on LinkedIn:
“I am thrilled to be joining Dr. Benjamin Schlechter, Dr. Pashtoon Kasi, and Phuong Ly-Gallagher for an engaging discussion on ‘The Next I-O Revolution’. On October 18th, Endpoints News will host a webinar where we will delve into the latest breakthroughs in the next-generation investigational immunotherapy treatments, including Agenus’ botensilimab and balstilimab, shedding light on their potential impact against traditionally ‘cold’ tumors, like colorectal cancer. Join us!
Registration is available here.”
Source: Steven O’Day/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46